PART I Item 1. B usiness. Overview We are a pharmaceutical company dedicated to maximizing the commercial potential of ORLYNVAH , the first oral branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Penems, including thiopenems and carbapenems, belong to a class of antibiotics more broadly defined as -lactam antibiotics, the original example of which was penicillin, but which now also includes cephalosporins. S...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-02-07 | 2024-12-31 | 0000950170-25-015857 | EDGAR | 143K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-037615 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008300 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001564590-22-011897 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012694 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010242 | EDGAR | — |
| 2019-03-25 | 2018-12-31 | 0001564590-19-009089 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-281557 | EDGAR | 89K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102400 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069802 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126736 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-096653 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058200 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063353 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041604 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021500 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024161 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017000 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0000950170-22-009792 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001193125-26-133247 | EDGAR | 1K words |
| 2026-03-27 | 0001193125-26-127785 | EDGAR | — |
| 2026-03-03 | 0001193125-26-088494 | EDGAR | — |
| 2026-03-02 | 0001193125-26-085646 | EDGAR | — |
| 2026-02-18 | 0001193125-26-057393 | EDGAR | — |
| 2025-12-12 | 0001193125-25-317728 | EDGAR | — |
| 2025-11-14 | 0001193125-25-281531 | EDGAR | — |
| 2025-10-16 | 0001193125-25-241556 | EDGAR | — |
| 2025-09-10 | 0000950170-25-113986 | EDGAR | — |
| 2025-08-28 | 0000950170-25-111974 | EDGAR | — |
193 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001659323 |
| Ticker | ITRM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L2 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report